Commentary on “Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel.” Peer A, Gottfried M, Sinibaldi V, Carducci MA, Eisenberger MA, Sella A, Leibowitz-Amit R, Berger R, Keizman D, Department of Oncology, Rambam Medical Center, Haifa, Israel.: Prostate 2014 Apr;74(4):433–40; doi:10.1002/pros.22765. [Epub 2013 Dec 11]

Autor: Trump, Donald
Zdroj: In Urologic Oncology: Seminars and Original Investigations May 2016 34(5):247-247
Databáze: ScienceDirect
Externí odkaz: